Farmaceutica REMEDIA Cash Flow Statement

Financials in millions RON. Fiscal year is January - December.

Millions RON. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	8.72	6.96	7.2	5.81	7.23
Depreciation & Amortization	2.41	2.63	5.06	4.02	1.11
Other Amortization	-	-	-	-	0.09
Other Operating Activities	4.52	9.37	10.96	-11.81	-5.8
Operating Cash Flow	15.65	18.96	23.22	-1.99	2.63
Operating Cash Flow Growth	-17.48%	-18.34%	-	-	-
Capital Expenditures	-1.33	-1.79	-1.38	-0.04	-0.04
Sale of Property, Plant & Equipment	0.11	0.35	0.35	0.2	0.48
Other Investing Activities	0.12	2.06	0.07	0.08	0.14
Investing Cash Flow	-1.09	0.62	-0.97	0.24	0.58
Repurchase of Common Stock	-0.57	-	-1.5	-	-
Common Dividends Paid	-3.35	-6.29	-4.19	-4.47	-13.35
Other Financing Activities	-0.25	-0.14	-0	-0.05	0.01
Financing Cash Flow	-4.17	-6.43	-5.7	-4.52	-13.35
Miscellaneous Cash Flow Adjustments	-	-0	-0.14	0.14	-
Net Cash Flow	10.39	13.16	16.41	-6.13	-10.13
Free Cash Flow	14.32	17.17	21.84	-2.03	2.59
Free Cash Flow Growth	-16.60%	-21.36%	-	-	-
Free Cash Flow Margin	1.88%	2.31%	3.68%	-0.38%	0.54%
Free Cash Flow Per Share	0.15	0.18	0.23	-0.02	0.03
Cash Interest Paid	-	-	-	0.07	-
Cash Income Tax Paid	7.3	5.31	1.61	1.29	1.55
Levered Free Cash Flow	18.15	19.84	21.82	1.54	10.32
Unlevered Free Cash Flow	18.18	19.9	21.9	1.64	10.39

Source: S&P Global Market Intelligence. Standard template. Financial Sources.